Benzinga | May 17, 2021 04:09PM EDT

Freeline Therapeutics Q1 EPS $(0.98) Up From $(1.85) YoY

Freeline Therapeutics (NASDAQ:FRLN) reported quarterly losses of $(0.98) per share. This is a 47.03 percent increase over losses of $(1.85) per share from the same period last year.